Speed to market: Driving medtech growth with an outsourced commercial team

Building and maintaining a specialist sales team in the UK medtech market presents significant commercial challenges. Long recruitment times, the pressure of covering vacant territories, and the high indirect costs of training, fleet, and administration can hinder growth and impact your bottom line. There is a more effective way to operate.

This webinar offers insights into a fast, flexible, and affordable commercial model designed for the medtech sector. Join CHASE to discuss how an outsourced team can help you navigate market uncertainties, establish a UK presence, and pilot new initiatives while minimising commercial risk. This agile approach is ideal for the current NHS environment, allowing you to capitalise on the opportunities presented in the "Fit for the Future" 10-Year Plan while navigating an evolving regulatory landscape.

This 45-minute session will cover:

• The flexible commercial model: Learn how an outsourced team provides a fast and adaptable alternative to traditional headcount, minimising risk and indirect costs.

• Accelerating your time to market: A practical model for establishing or expanding a UK presence quickly to avoid missing commercial opportunities.

• Capitalising on the NHS opportunity: Understand the strategic direction of the "Fit for the Future" 10-Year Plan and how it creates a pathway for medtech adoption.

• Navigating market access: An analysis of the evolving regulatory landscape, including the expansion of NICE's technology appraisal process to cover devices and diagnostics.

• A proven, integrated approach: Examine a service model where outsourced professionals are fully integrated into your teams, ensuring seamless representation in front of the customer.

Meet your speakers ‍

Graham Hawthorne, CEO, CHASE
‍As CEO of CHASE, Graham brings 30 years of leadership experience from roles within start-up, mid-sized, and multinational pharmaceutical service organisations. He has a strong track record in strategy, operations, and business development across the UK medtech and pharmaceutical sectors. Since joining CHASE in 2012, Graham has driven revenue growth across both outsourced and permanent recruitment divisions. His extensive network of senior industry contacts and focus on stakeholder management provide invaluable insight into creating effective commercial strategies for companies operating in the UK.

Tim Wheeldon, Consultant - Commercial Transformation 
Tim is a dynamic medtech leader with extensive experience driving commercial transformation at country and regional levels, managing budgets up to €1bn across 50+ countries. He possesses a strong track record in aligning strategy with financial goals and market impact, powered by a value-based approach to commercial excellence, segmentation, and execution. Tim's focus on innovation and talent development provides valuable perspective on building high-performing, adaptable commercial structures within the medtech sector.

(Host) Cat Metcalfe, Strategy & Insights Director, CHASE
‍Cat has 18 years of experience helping life sciences organisations understand and meet the needs of the NHS. Having worked extensively on patient-empowering programmes and medical education, Cat is passionate about finding collaborative, win-win solutions that benefit patients, the NHS, and its partners. She will host the discussion, ensuring it addresses the key strategic questions facing today's medtech leaders.